EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Adverum Biotechnologies, Inc.

(Exact name of Registrant as Specified in its Charter)

Table 1 – Newly Registered Securities

Security Type

Security
Class

Title

Fee

Calculation
Rule

Amount
Registered⁽¹⁾

Proposed
Maximum
Offering
Price Per
Unit

Maximum
Aggregate
Offering
Price

Fee Rate

Amount of
Registration
Fee

Equity

Common Stock

Rule 457(c) and (h)⁽²⁾

81,360⁽³⁾

$5.35⁽²⁾

$435,276

0.00015310

$66.64

Equity

Common Stock

Rule 457(h)⁽⁴⁾

68,640^{(3), (5)}

$6.00⁽⁴⁾

$411,840

0.00015310

$63.06

Total Offering Amounts

–

$847,116

–

$129.70

Total Fees Previously Paid

–

Total Fee Offsets

–

Net Fee Due

–

$129.70

(1)

Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Registrant’s Common Stock that become issuable under the plans set forth herein by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Registrant’s Common Stock.

(2)	Estimated in accordance with Rules 457(c) and (h) solely for the purpose of calculating the registration fee on the basis of $5.35 per share, the average of the high and low prices of the Registrant’s Common Stock on December 16, 2024 as reported on The Nasdaq Capital Market.

(3)	Represents shares of Common Stock that were added to the shares reserved for issuance under the Registrant’s 2017 Inducement Plan, as amended and restated (the “2017 Plan”).

(4)	Calculated pursuant to Rule 457(h) solely for the purpose of calculating the registration fee. The proposed maximum offering price per share and proposed maximum aggregate offering price are calculated using the exercise price for such shares.

(5)	Represents shares of Common Stock that may be issued upon the exercise of outstanding options granted under the 2017 Plan.